RxDoctor Payments Data

Leroy Nickles, MD

Emergency Medicine · New York, NYNPI 1710070412

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $47,690 of the $64,158 with a category attached, or 74.3%. Genentech USA, Inc. accounts for 63.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $40,757 and has fallen 99.3% since, to $300 in 2024. Among emergency medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,158in general payments, 2019–2025

Across 93 payments — averaging $689.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$41K
  • AstraZeneca$23K
  • Johnson & Johnson$29
  • Portola Pharmaceuticals, LLC$29
  • E.r. Squibb & Sons, L.L.C.$23
  • AbbVie$19
  • plus $11 from 1 others

What the payments were for

  • Speaking & faculty fees$47,69074%
  • Travel & lodging$13,73821%
  • Food & beverage$2,7294%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,158 in reported general payments places this provider in the 95th percentile of 4,167 emergency medicine providers in New York.

See all emergency medicine providers in New York

Medicare billing

Part B allowed, 2024
$14,580
Medicare patients
92
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other emergency medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →